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Abstract
Light amplification by stimulated emission of radiation (lasers) is a device that typically
generates electromagnetic radiation of uniform wavelength, phase, and polarization.
The term low‐level laser therapy (LLLT) is broadly defined as the therapeutic benefit of
lasers. This review aims to discuss the positive effects of LLLT on skin wounds, diabetic
foot ulcers,  and burn healing.  Different LLLT protocols have been widely used as
treatment for these conditions to accelerate tissue regenerative processes.  We have
classified eligible papers in the fields of skin wounds, ulcers, and burns into in vivo and
in vitro experimental  studies  and clinical  trials  that  evaluated the use of  LLLT as
treatments that promote healing. An electronic search of scientific peer reviewed papers
was conducted in the PubMed database. Our search has shown that the use of LLLT in
biology  and  medicine  is  growing  rapidly,  and  advancements  in  LLLT  research
dramatically improved the clinicians’ ability to safely and effectively treat wounds and
ulcers. There is increased clinical use of laser for wound and ulcer treatment. Several
recent studies have confirmed the potential beneficial effects of LLLT for wound healing.
Keywords: low‐level laser therapy, skin wound, diabetic foot ulcer, burn
1. Introduction
The term low‐level laser therapy (LLLT) is broadly defined as the therapeutic benefit of lasers.
After Professor Mester from Hungary first revealed the therapeutic importance of lasers,
different wavelengths of continuous wave (CW) LLLT have been shown to promote healing
in skin from healthy humans and animals, as well as a number of experimental pathological
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cases. Different LLLT protocols have been widely used in numerous medical situations with
the intent to accelerate the regenerative processes of tissues.
In this review, the author characterized eligible papers into in vivo and in vitro experimental
studies and clinical trials that evaluated the use of LLLT on skin wounds for promotion of
healing. The author conducted an electronic search of scientific peer reviewed papers in the
PubMed database of English language studies published from 2004 to 2016 with the keyword
“low‐level laser therapy.” As inclusion criteria, the author chose articles with availability of
access to the full text. This review intended to show the positive effects of LLLT on healing of
skin wounds, diabetic foot ulcers, and burns. Initially, the author introduced wounds, ulcers,
and burns and showed their importance. Next, a number of important related papers in the
field were reported.
2. Definition
Devices that provide light amplification by stimulated emission of radiation (LASERS)
typically generate electromagnetic radiation of a uniform wavelength, phase, and polarization.
In 1960, Theodore Maiman has originally described a ruby laser. A laser is described as a source
of light or radiation energy [1].
3. History
The term “LLLT” is broadly applied to the therapeutic effects of lasers; other terms, such as
low power laser therapy, laser biomodulation, laser bioactivation, laser biostimulation, laser
irradiation, and laser photostimulation, may be substituted for LLLT. In this review, the
author have chosen the term LLLT photostimulation because of the observed stimulatory
effects of the laser beam and photochemical nature of its interaction with biological systems.
LLLT is a special type of laser that influences biologic systems through nonthermal means
[2]. The use of LLLT as a therapeutic modality has originated from Eastern Europe approx‐
imately 50 years ago [2]. In 1967, Professor Mester, an employee of Semmelweis University
in Budapest, Hungary, observed that applying laser light to the shaven backs of mice could
cause more rapid regrowth of hair compared to unshaven mice [3]. He reported that the
helium‐neon (He‐Ne) laser had the capability to promote wound healing in mice [4].
Professor Mester applied these findings to humans when he used lasers to treat patients with
nonhealing skin ulcers [5, 6]. The clinical applications of LLLT have become the leading edge
of clinical research in several countries, such as the former USSR, Japan, Canada, Australia,
United Kingdom, China, and several Scandinavian countries. The history, origin, and
development of various lasers are well authorized [2]. The clinical application of laser
photobiostimulation is growing rapidly. Several review articles that explain the clinical
applications of LLLT have been published [2]. LLLT is currently considered not only as a
therapeutic procedure primarily used for relief of inflammation, edema, and chronic joint
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disorders; escalate healing of the wounds, deeper tissues, and nerves; but also as a treatment
for neurological disorders and pain [7].
4. Objective
LLLT exposes tissues and cells to low levels of red and near infrared (NIR) and IR light. This
treatment is introduced to as “low level” because of usage of light at lower energy densities in
comparison to other types of laser therapy such as cutting, ablation, and thermal coagulation
of tissue. LLLT is also defined as “cold laser” therapy because of the lower power densities
used compared to those needed to produce tissue heating [7]. LLLT is currently used to treat
a wide variety of diseases in which a large number of laser parameters such as the energy
density, wavelength, pulse structure, power density, and timing of the applied light must be
chosen for each treatment. A less than optimal choice of parameters can lead to not only
reduced effectiveness of the treatment but also result in negative therapeutic outcomes. Thus,
numerous published results on LLLT include negative findings simply because of an inap‐
propriate choice of light source and dosage. This choice is particularly important because of
the optimal dose of light needed for any particular application; doses higher or lower than this
optimal value may have no therapeutic effect. LLLT is defined by a biphasic dose response:
lower doses of light are often more advantageous than high doses [7]. This review aims to
discuss the positive effects of LLLT on healing diabetic wounds and burns. Low‐level laser
energy density (J/cm2) calculation: power (W) × duration of laser radiation (s)/laser beam
surface area (cm2).
5. Wound healing
Wound healing, which is a normal physiological process, takes places in four particular phases:
hemostasis, inflammation, proliferation, and remodeling. For a successful healing process, all
four phases must follow in the appropriate sequence and time. Numerous factors can put
adverse effects on different phases of this process, resulting in an inappropriate wound healing
process. The most important factors that influence healing of the cutaneous wound and the
potential cellular and/or molecular mechanisms involved consist of local and systemic factors.
Local factors include oxygenation, infections, foreign bodies, and venous sufficiency, whereas
systemic factors comprise age and gender, sex hormones, stress, diseases, such as diabetes
mellitus (DM), keloids, fibrosis, hereditary healing disorders, jaundice, uremia, obesity,
medications (glucocorticoid steroids, nonsteroidal anti‐inflammatory drugs), chemotherapy,
alcoholism, and smoking, as well as immunocompromised conditions (cancer, radiation
therapy, AIDS, and nutrition). A better understanding of the effects of these factors on the
wound healing process may lead to therapeutics that accelerate wound healing and resolve
impaired wounds. However, the influences of these factors are not mutually exclusive. One or
multiple factors may play a role in any of the individual phases by contributing to the overall
outcome of the healing process [8].
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6. Diabetic wound healing in animals and patients (diabetic foot ulcers
(DFU))
DM is the general name for a heterogeneous group of metabolic disorder characterized by high
blood glucose levels that result from defects in insulin secretion and/or action [9]. The per‐
centage of the population diagnosed with DM continues to increase. A study projects that as
many as one in three US adults may have DM by the year 2050 if current trends continue. The
expense of DM in the United States, at more than $174 billion per year in 2007, is anticipated
to become an increasingly large financial burden in the future [10].
DFUs are a common problem among individuals with DM. These ulcers are among the most
serious complications of DM that may result in amputation and mortality [11]. The prevalence
of DFU in people with DM vary from 4% to 10% with a lifetime incidence as high as 25% [12].
Treatment of diabetic foot is extremely hard because these wounds are delineated by delayed
healing; often result in chronic wound [13]. It has been reported that the 5‐year mortality
leading to lower extremity amputations may be as high as 68% [14]. Therefore, successful
treatment of diabetic ulcers is a field of huge importance [15].
Many elements considered to be sources for the lack of healing in diabetic wounds involve
peripheral neuropathy, the presence of an impaired immune system, peripheral microvascular
disease, glycation of hemoglobin that leads to inadequate oxygen delivery to tissues, altera‐
tions in the red blood cell membrane [13] due to glycation, interchange in the proportion of
type III to type I collagen in the skin [16], impaired biomechanical properties of the diabetic
skin [17], impaired proliferation of skin fibroblasts [18], and impaired l‐lactate production [19].
The diabetic wound is a disorder of the wound healing process, especially in the inflammatory
and proliferative phases [13], pathologic angiogenesis [20], and a significant diminishing of
the tensile strength of wound repair, detected in studies on diabetic animal models [21].
According to a review of the literature, numerous in vitro and in vivo studies, as well as clinical
trials have reported positive effects of LLLT on the wound healing process both in animals and
human patients.
7. Literature review
Dahmardehei et al. have stated that significant numbers of patients in burn centers are
diabetics. The healing process in these patients is more difficult due to complications attributed
to diabetes. Despite the fact that the gold standard treatment for a grade 3 burn ulcer patient
is split‐thickness skin grafting (STSG), however in diabetic patients, the rate of graft rejection
and organ amputation is high due to impaired tissue perfusion. Previous studies show that
LLLT accelerates fibroblast proliferation, increases collagen synthesis and tissue perfusion, and
accelerates wound healing. Dahmardehei et al. have recommended a new therapeutic method
for improving the healing process with better prognosis for these patients. Their study enrolled
type II diabetes patients with 13, grade 3 burn ulcers considered candidates for amputation.
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In these patients, the grade 3 burn ulcers were treated by a 650 nm red laser light at 2 J/cm2 for
the bed of the ulcer and an 810 nm infrared laser light at 6 J/cm2 for the margins, along with
intravenous LLLT with a 660 nm red light, before and after STSG. The results showed complete
healing for all patients considered candidates for amputation [22]. Góralczyk et al. reported
that that chronic hyperglycemia was the source of endothelial activation. On the other hand,
the inflammatory process in DM has been associated with the secretion of inflammatory
cytokines by endothelial cells, such as tumor necrosis factor‐alpha (TNF‐α) and interleukin 6
(IL‐6). Góralczyk et al. evaluated the effects of 635 and 830 nm wavelength LLL irradiation on
the secretion of inflammatory factors (TNF‐α and IL‐6) in an endothelial cell culture‐human
umbilical vein endothelial cell (HUVEC) line under hyperglycemic conditions. Adverse effects
of hyperglycemia on vascular endothelial cells might be recovered by the action of LLLT,
especially at a wavelength of 830 nm. LLLT decreased TNF‐α concentration in the supernatant
and improved cell proliferation [23]. Lau et al. carried out a study to investigate the biophotonic
effect of irradiance on collagen production in a rat model of a diabetic wound. The skin’s tensile
strength was a parameter to characterize the wound. The rat models received intravenous
injections of streptozotocin (STZ) to induce diabetes. Skin‐breaking strength was measured.
The experimental animals were treated with an 808 nm diode laser at two power densities of
0.1 and 0.5 W/cm2. The tensile strength was optimized after treatment with a high‐power diode
laser. The photostimulation effect was shown by the accelerated healing process and enhanced
tensile strength of the wound. Lau et al. concluded that LLLT facilitated collagen production
in diabetic wound healing [24]. Sharifian et al. assessed the influence of pulsed wave (PW)
LLLT on healing of the diabetic wound in diabetic (STZ‐D) rats. They divided rats into two
groups: nondiabetic and diabetic. They induced type I DM in the diabetic rat group through
injection of STZ. The rats were submitted to two full‐thickness skin incisions on the dorsal
region of each one. One month after the injection of STZ, wounds of the nondiabetic and
diabetic rats were subjected to a pulsed, infrared 890 nm wavelength laser with an 80 Hz
frequency and 0.2 J/cm2 energy density for each wound point. PW LLLT significantly acceler‐
ated the numbers of macrophages, fibroblasts, and blood vessel sections in comparison with
the corresponding control groups. Semiquantitative analysis of basic fibroblast growth factor
(bFGF) gene expression indicated significant increase in gene expression in both nondiabetic
and diabetic rats following LLLT [25]. Houreld reported that due to advancements in laser
technology, irradiation of diabetic wounds with low‐intensity laser irradiation (LILI) or
phototherapy has vastly accelerated wound healing. At the correct laser parameters, LILI
increased migration, viability, and proliferation of diabetic cells in vitro. A stimulatory effect
on the mitochondria that resulted in increased adenosine triphosphate (ATP) was observed.
In addition, LILI also showed anti‐inflammatory and protective effects on these cells. In light
of the continual threat of diabetic foot, infection, and amputation, new better therapies and the
developing of wound healing research deserves better prioritization [26]. Esmaeelinejad and
Bayat evaluated the effects of LLLT on human skin fibroblasts (HSFs) cultured in high glucose
concentration and physiological glucose condition media. Release of IL‐6 and bFGF was
evaluated by enzyme‐linked immunosorbent assay (ELISA). Statistical analysis demonstrated
that certain previously mentioned laser doses (energy densities) promoted the release of IL‐6
in HSFs which were cultured in high glucose concentration medium in comparison with
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nonirradiated HSFs cultured in the same medium. LLLT with 2 J/cm2 energy density enhanced
secretin of bFGF and IL‐6 from fibroblast cultured in media mentioned above (hyperglycemic
condition media). When HSFs were cultured in physiologic glucose concentration medium
during laser irradiation, LLLT more effectively released IL‐6 and bFGF [27]. In a single case
study, Dixit et al. outlined the possible effect of LLLT on delayed wound healing and pain in
a diabetic patient with chronic dehiscent sternotomy. After irradiation, they observed prolif‐
eration of healthy granulation tissue with decreased scores from the pressure ulcer scale of
healing for sternal According to the results, LLLT could be a new potential treatment for
chronic sternal dehiscence following coronary artery bypass graft, as it reinforced wound
healing with an early closure of the wound deficit [28]. Fathabadie et al. conducted a study on
the influence of PW LLLT on mast cells in wounds of nondiabetic and diabetic rats. The
induction of type I DM and LLLT protocol was the same as Sharifian et al.’s study [25]. They
assessed mast cell numbers and degranulation in all subgroups at 4, 7, and 15 days after
infliction of the wounds. According to the paired t‐test, there were significantly more total
numbers of laser‐treated mast cells compared to the placebos in the nondiabetic and diabetic
groups. They observed significantly more granulated mast cells compared with degranulated
mast cells for all laser‐treated mast and placebo mast cells in the nondiabetic and diabetic
groups [29]. Aparecida Da Silva et al. performed a study not only to determine if LLLT restored
the balance between mRNA expression of matrix metalloproteinases (MMP)‐2 and MMP‐9 but
also to determine the ratio between collagen types I and III during the diabetic wounds healing.
The diabetes model was induced efficiently by STZ as demonstrated through increased levels
of blood glucose. A diode laser (50 mW, 660 nm, 4 J/cm2, 80 s) was administered once after
scare induction. After LLLT, the rats were euthanized. The scarred areas were collected for
MMP‐2 and MMP‐9 mRNA and histological analyses (inflammation and types I and III
collagen). The results determined that scare significantly increased MMP‐2 and MMP‐9
expressions in untreated diabetic rats compared to nondiabetic rats. LLLT significantly
reduced MMP‐2 and MMP‐9 expressions compared with untreated diabetic rats. Aparecida
Da Silva et al. concluded that LLLT altered the expression of MMP‐9, stimulated collagen
production, and increased the total percentage of collagen type III in diabetic animals [30].
Esmaeelinejad et al. evaluated the effects of LLLT on HSFs cultured in high glucose concen‐
tration medium. HSFs were cultured either in physiologic glucose (5.5 mM/l) or high glucose
(11.1 and 15 mM/l) media. LLLT was performed with a He‐Ne laser unit at energy densities of
0.5, 1, and 2 J/cm2. The viability and proliferation rate of these cells were determined by MTT
assay. The results indicate that LLLT stimulate the viability and proliferation rate of HSFs,
which were cultured in physiologic glucose medium compared to their control cultures. LLLT
had stimulatory effects on the proliferation rate of HSFs cultured in high glucose concentra‐
tions compared with their control cultures. Esmaeelinejad et al. announced that HSFs origi‐
nally cultured for 2 weeks in high glucose concentration attended to culture in physiologic
glucose during laser irradiation increase cell viability and proliferation. Therefore, LLLT had
a stimulatory effect on these HSFs [31]. Dadpay et al. studied the effect of LLLT in experimen‐
tally induced diabetic rats. They generated two full thickness skin incisions on the dorsal
regions of each rat. The healthy (nondiabetic) groups received a pulsed‐infrared 890 nm laser
with an 80 Hz frequency and 0.03 J/cm2 for each wound point in the first group and 0.2 J/cm2
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in the second group. Laser‐treated diabetic wounds of the animals subjected to the same
pulsed‐infrared laser treatments as the second group for each wound point. Laser irradiation
with 0.03 J/cm2 significantly diminished the maximum load for wound repair in healthy rats.
Laser irradiation with 0.2 J/cm2 significantly escalated the maximum load in wounds from the
healthy control and diabetic groups [32]. Peplow et al. have used a 660 nm laser diode in genetic
diabetic mice to promote the healing process of wounds covered with a Tegaderm™ HP
dressing that causes delayed contraction (splinted wounds). Possibly, the stimulation of
healing could be due to the potential diabetes‐modifying properties of laser light. Nonwound‐
ed diabetic mice and wounded diabetic mice was subjected to the 660 nm laser to at the same
dose and location. They measured body weight and water intake of the mice. The left flank in
the experimental group received 660 nm and 100 mW of irradiation 20 s/day for 7 days. There
were no significant differences in body weight and water intake over 22 days between mice in
the experimental and control groups. On day 14, the mean blood plasma glucose level did not
significantly differ between the two groups. There was no glycated hemoglobin A1c detected
in the samples. Peplow et al. concluded that irradiation of the left flank in diabetic mice with
the 660 nm laser system did not have a significant hypoglycemic effect. The laser‐stimulated
healing of wounds in diabetic mice resulted from cellular and biochemical changes to the
immediate wound environment [33]. Jahangiri et al. studied the effects of combined 670 and
810 nm diode lasers on diabetic wound healing parameters in rats. Two intervention (laser)
groups underwent LLLT using 670 nm diode laser (500 mW, 10 J, 48 s) in the wound context
and 810 nm diode laser (250 mW, 12 J, 50 s) to the wound margins. Never could they find
statistically significant differences between the diabetic and nondiabetic groups in the wound
area, percentage of open wound area, and wound healing rate by the repeated measurements.
After 7 days of LLLT in the nondiabetic group, urine excretion significantly increased com‐
pared with the control group. Jahangiri et al. showed that no significant difference existed
between the LLLT and control groups. The increased urine volume in nondiabetic rats after
LLLT was an incidental observation that deserved future study [34]. Mirzaei et al. examined
the impact of LLLT on cellular changes in organ culture and cell culture of skin from STZ‐D
rats. Type I DM was induced in rats by STZ. Fibroblasts extruded from the samples were
proliferated in vitro and another set of samples were cultured as the organ culture. The
researchers used an He‐Ne laser. They administered 0.9–4 J/cm2 energy densities four times to
each organ and cell culture. The organ cultures were analyzed by light and transmission
electron microscopy. Cell proliferation was evaluated by the MTT assay. Statistically, 4 J/cm2
irradiation significantly increased the fibroblast numbers compared with the sham‐exposed
cultures [35].
8. Skin burn healing
Burn injuries are common traumatic injuries that cause considerable mortality and morbidity.
Additionally, they are among the most expensive traumatic injuries due to the extended
hospitalization and rehabilitation, as well as costly wound and scar treatments [36]. Annually
in the United States, 1.25 million burn patients are treated. Of these, at least 50,000 require
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hospitalization [36]. Burn wounds generate special interest due to the large numbers of burn
cases encountered. These wounds can generate a destructive effect functionally and cosmeti‐
cally, which necessitates the search for a more efficient cure [37]. LLLT has beneficial effects on
burn healing.
9. Literature review
Khoshvaghti et al. studied the effects of LLLT on mast cells in a third‐degree burn rat model.
Rats from all groups each received third‐degree burns at three different locations. The first
burn site on group I rats subjected to 890 nm pulsed laser, with 0.924 J/cm2 energy density.
0.2% nitrofurazone cream was administrated for treatment of the second burn site on both
groups of rats. They evaluated mast cell degranulation and numbers at each burn site on each
group of rats. Analysis of variance on day 4 showed significantly lower total numbers of mast
cells in the laser‐treated burn sites compared with the other burn sites in both groups of rats.
On day 8, the total numbers of mast cells were significantly lower at the laser‐treated burn
sites compared with the other burn sites. On day 13, there were significantly lower numbers
of types I and II mast cells at the laser‐treated burn sites compared with the other burn sites.
Khoshvaghti et al. [38] concluded that LLLT significantly declined total numbers of mast cells
through the proliferation and remodeling phases of healing in a rat model of third‐degree
burn. Ezzati et al. investigated the influence of PW LLLT on healing of a deep second‐degree
burn model in rats. In their study, two groups of laser‐treated burns were treated by a 3000
Hz pulsed infrared diode laser that had 2.3 or 11.7 J/cm2 energy densities, respectively.
Treatment response was assessed both microbiologically and macroscopically. The incidence
of Staphylococcus aureus diminished significantly in group 3 in comparison to group 1 on day
28. Analysis of variance showed that the 11.7 J/cm2 LLLT significantly increased the wound
closure rate at 2 and 3 weeks after infliction of the burn when compared with placebo burns.
Independent sample t‐tests demonstrated that LLLT with 11.7 J/cm2 significantly enhance the
wound closure rate though 4 weeks after infliction of the burn in comparison to the control
burns. Ezzati et al. concluded that pulsed LLLT with 11.7 J/cm2/890 nm of a deep second‐
degree burn model in rats significantly escalated the rate of wound closure compared with
the control burns [39]. Ezzati et al. studied the influence of PW LLLT on the healing process
of a third‐degree burn in a rat model. They treated two groups of rats with a 3000 Hz‐pulsed
infrared diode laser that had 2.3 or 11.7 J/cm2 energy densities and evaluated the response to
treatment both microbiologically and macroscopically. They indicated that the incidence of
Staphylococcus epidermidis, Lactobacillus, and Diphtheria diminished significantly in the laser‐
treated groups compared to the other groups by the chi‐square test. The independent sample
t‐test illustrated that LLLT with 11.7 J/cm2 energy density significantly escalated the wound‐
closure rate at 3 and 4 weeks after infliction of the burn compared with the control burns [40].
Vasheghani et al. evaluated 80 Hz pulsed infrared diode LLLT for third‐degree burn healing
in rats. The laser‐treated burns were exposed to an 80 Hz pulsed 890 nm infrared diode laser
at 0.396 J/cm2, three times per week. Burn wounds were clinically examined. There were a
significantly higher number of laser‐treated burns that closed compared to the controls. The
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paired Student’s t‐test indicated that the wound closure rate of laser‐treated burns was
significantly longer than the control burns. Chi‐square tests showed no significant difference
between each microorganism (Staphylococcus epidermis, S. aureus, and Pseudomonas aerugino‐
sa). Vasheghani et al. concluded that LLLT with an 80 Hz pulsed infrared diode laser
accelerated third‐degree burn healing in rats [41]. Bayat et al. studied the effects of LLLT on
mast cell number during the inflammation, proliferation, and remodeling phases of the
wound healing process of experimental burns. In the two laser‐treated groups, burned areas
were subjected to the LLLT with a He‐Ne laser at energy densities of 38.2 or 76.4 J/cm2. They
observed that on day 7 in the first laser group, there were significantly more total numbers
of mast cells compared with the other groups. On day 16 in the nitrofurazone‐treated group,
the total number of mast cells was significantly higher compared with the control, first laser,
and normal groups [42]. In another study, Vashghani et al. investigated the effect of LLLT
administered with a He‐Ne laser on mast cell number and degranulation in rats with second‐
degree burns. All rats received deeply inflicted second‐degree burns. In the two laser‐treated
groups, the burns received daily LLLT, with energy densities of 1.2 or 2.4 J/cm2. In the fifth
group, the burns were treated topically with daily administration of 0.2% nitrofurazone
cream. Vashghani et al. concluded that administration of LLLT for deep second‐degree
cutaneous burns in rats not only significantly enhanced the number of intact mast cells during
the inflammatory and proliferative phases of healing but also diminished the total number
of mast cells during the remodeling phase [43]. In another study, Bayat et al. researched the
effects of LL He‐Ne LT on burn healing. The two laser treated groups, underwent daily
treatment with LL He‐Ne LT at energy densities of 1.2 or 2.4 J/cm2. The response to treatment
was assessed histologically and microbiologically. Analysis of variance demonstrated
significantly greater mean blood vessel sections in the 1.2 J/cm2 laser group compared with
the other groups. Compared with the nitrofurazone‐treated group, the mean depth of new
epidermis in the 2.4 J/cm2 laser group on day 16 was significantly lower. P. aeruginosa and S.
aureus grew in more than 50% of samples obtained from control group, however these bacteria
did not grow in the samples from the 2.4 J/cm2 laser group. Bayat et al. concluded that LL
He‐Ne LT stimulated the destruction of S. aureus and P. aeruginosa in rats with third‐degree
burns. However, the histological evaluation demonstrated that LL He‐Ne LT not only made
a significant escalation in the mean blood vessel sections on day 7 after infliction of the third
degree burns but also reduced the mean of the depth of new epidermis on day 16 after
infliction of these burns in rats [44]. Bayat et al. studied the effects of two different doses of
LLLT on healing deep second‐degree burns. They inflicted a deep second‐degree burn in each
rat. The control group burns remained untreated. The two laser treated group burns were
irradiated daily with LL He‐Ne LT with energy densities of 1.2 or 2.4 J/cm2. The response to
treatments was assessed histologically and microbiologically. S. epidermidis was found in the
70% of the rats’ wounds in the laser‐treated groups in comparison to 100% of rats in the control
group. Despite the fact that they found S. aureus in 40% of the rat wounds which were treated
by nitrofurazone, they did not find this bacterium in the wounds of the laser treated and
control groups. Bayat et al. determined that LLLT of deep second‐degree burns made
significant reduction in the number of macrophages and depth of the new epidermis.
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Moreover, this treatment diminished the incidence of S. epidermidis and S. aureus [45]. It seems
that special LLLT protocols have potential antimicrobial activity.
10. Cellular and tissue mechanisms of LLLT
It appears that LLLT not only has a great range of effects at the molecular, cellular, and tissue
levels and also its specific modes of action may vary among different applications. Within the
cell, there is strong evidence to suggest that LLLT causes the mitochondria [46] to enhance ATP
production [27, 31], modification of reactive oxygen species (ROS), and induce transcription
factors [47].
LLLT also enhances the proliferation, maturation, and motility of fibroblasts, and increases the
production of bFGF [48]. When a chromophore absorbs a photon of light (laser) in the treated
cells, an electron in the chromophore has the potential to become excited and move from low‐
energy orbit to a higher energy orbit [49]. The system can then use this stored energy to achieve
various cellular tasks. There are several pieces of data that suggest that a mitochondria
chromophore is as the initial LLLT target. Radiation of tissue with light makes mitochondrial
products such as ATP, nicotinamide adenine dinucleotide (NADH), proteins, and RNA, as well
as a reciprocal augmentation in oxygen consumption to increase. Various in vitro experiments
have showed that cellular respiration is upregulated when mitochondria are subjected to a He‐
Ne laser or other forms of illumination [50]. The relevant chromophore can be detected by
matching the action spectra for the biological response to light in the NIR range to the
absorption spectra of the four membrane‐bound complexes identified in mitochondria. This
procedure demonstrates that complex IV or cytochrome c oxidase (CCO) is the essential
chromophore in the cellular response to LLLT. CCO that consists of two copper and two heme‐
iron centers (components of the respiratory electron transport chain) is a large transmembrane
protein complex [51]. The high‐energy electrons are passed from electron carriers through a
series of transmembrane complexes (such as CCO) to the final electron acceptor which makes
a proton gradient used to produce ATP. Therefore, the administration of light directly affects
ATP production by influencing one of the transmembrane complexes in the chain. Especially,
LLLT increases ATP production and electron transport [52].
11. Contraindications and precautions
11.1. Contraindications
Direct irradiation of the eyes, within 4–6 months after radiotherapy, hemorrhaging region,
locally to the endocrine glands [53].
11.2. Precautions
Epilepsy, fever, malignancy, to the low back or abdomen during pregnancy or menstruation,
embryo or fetus, over the gonads, epiphyseal lines in children confused or disoriented patient,
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area of decreased sensation, infected tissue, sympathetic ganglia, vagus nerves, or cardiac
region in patients with heart disease [53].
12. Conclusion
The effects of LLLT depend on the physiological state of the target cells, type of laser, radiation
wavelength, energy density, and number of laser sessions. The biostimulation efficiency of
LLLT is also dependent on the delivered energy density, which appears to be restricted to a
very narrow therapeutic window. Compared with CW LLLT devices, PW LLLT devices
provide more laser parameters. By investigating different values of these parameters, research
models can be more effectively studied in these devices (PWLLLT) in comparison with CW
LLLT devices, with the purpose of achieving better outcomes [54]. There were different LLLT
protocols for different tissues. Clinical applications of LLLT have significantly impacted
medicine and attracted the interest of clinicians, the public, and the media. The use of LLLT in
biological applications and medicine is growing rapidly; advances in LLLT research have
dramatically improved the clinician’s ability to safely and effectively treat various medical
conditions. According to several studies if the general condition of patients (such as blood
glucose level, hydration, Na level, etc.) is controlled, LLLT can be useful for the treatment of
diabetic foot ulcer. Nevertheless, additional research is required to elucidate the exact mech‐
anism of laser photostimulations action at the cellular and molecular levels. Standardized
treatment parameters of LLLT should be followed. Efforts should be made to evaluate precise
dosimetry for skin wounds, DFUs, and burns.
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